Viewing nowCombinationTwin Plus Tablet 40/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 201702160 · Approved 2017.04.27 · Insurance code 660703090
Treatment of essential hypertension not controlled with monotherapy
This medication helps effectively lower blood pressure in patients with essential hypertension who find it difficult to control blood pressure with amlodipine or telmisartan alone. This allows for easier management of hypertension and reduces the risk of complications.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this drug; however, direct switching to this drug may be considered when blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this drug 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 mg and 80/10 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
○ Children: The safety and efficacy have not been established in pediatric patients aged 18 years or younger; therefore, administration of this drug is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters; thus, women who are pregnant or may become pregnant should not take it. Additionally, patients who are allergic to any of this medication's active ingredients or similar substances, those with severe hepatic impairment, patients with significantly impaired cardiac function, and patients with hypotension should not use this medication. Patients with liver or biliary dysfunction, gastrointestinal disorders, impaired renal function, elderly patients, and patients with renal failure should use this medication with caution and follow a doctor's instructions. Common side effects include dizziness, edema, and hypotension; therefore, caution is needed when driving or operating machinery. There is a risk of elevated potassium levels in the blood, so caution is advised when taking potassium supplements or potassium-rich foods, and patients with renal impairment should have regular blood tests. Interactions may occur when used with other medications, especially in patients taking diuretics, potassium supplements, lithium, digoxin, warfarin, or non-steroidal anti-inflammatory drugs, and it is essential to consult with a doctor or pharmacist. In the case of overdose, symptoms such as hypotension, dizziness, and cardiac function decline may occur, requiring immediate medical attention. This medication is not recommended for children as its safety and efficacy have not been sufficiently established, and breastfeeding women should also avoid it. Store this medication out of reach of children, away from moisture and direct sunlight, and it is best to take it immediately after opening.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is important to store it at a temperature between 1 and 30 degrees Celsius to maintain the drug's effectiveness.
White or off-white rectangular tablet
30 tablets/box [10 tablets/Alu-Alu X 3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.